Literature DB >> 2893593

The effect of somatostatin on experimental intestinal obstruction.

S J Mulvihill1, T N Pappas, E W Fonkalsrud, H T Debas.   

Abstract

The effect of somatostatin (SS-14) was tested in an anesthetized rabbit model of closed-loop ileal obstruction. Experimental groups included (1) immediate treatment (N = 6) receiving SS-14 2,000 pmol X kg-1 X h-1 intravenously (I.V.) beginning at the time of ileal obstruction, (2) delayed treatment (N = 5) receiving SS-14 beginning 6 hours following ileal obstruction, and (3) control (N = 6) receiving only hydration. After 24 hours, all rabbits were killed. Significantly decreased intestinal luminal volume and sodium and potassium output was observed with both immediate and delayed SS-14 treatment when compared to control. Additionally, the gross and microscopic pathologic features of intestinal distension, inflammation, and necrosis seen in control rabbits were absent in rabbits treated with SS-14. The known broad spectrum of physiologic activity of SS-14 on the gastrointestinal tract appeared beneficial in this rabbit model of intestinal obstruction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893593      PMCID: PMC1493368          DOI: 10.1097/00000658-198802000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Mechanical intestinal obstructions; a study of 1,252 cases.

Authors:  G A SMITH; J F PERRY; E G YONEHIRO
Journal:  Surg Gynecol Obstet       Date:  1955-06

2.  The absorption and secretion of fluid and electrolytes by the obstructed bowel.

Authors:  R Shields
Journal:  Br J Surg       Date:  1965-10       Impact factor: 6.939

3.  Severe diarrhea after colonic pseudo-obstruction: treatment with somatostatin.

Authors:  S Mulvihill; E Passaro; H Debas; T Yamada
Journal:  N Engl J Med       Date:  1984-02-16       Impact factor: 91.245

Review 4.  Somatostatin (second of two parts).

Authors:  S Reichlin
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

Review 5.  Somatostatin and the gastrointestinal tract.

Authors:  R Arnold; P G Lankisch
Journal:  Clin Gastroenterol       Date:  1980-09

6.  Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

Authors:  P N Maton; T M O'Dorisio; B A Howe; K E McArthur; J M Howard; J A Cherner; T B Malarkey; M J Collen; J D Gardner; R T Jensen
Journal:  N Engl J Med       Date:  1985-01-03       Impact factor: 91.245

7.  In vitro effects of somatostatin on ion transport in rabbit intestine.

Authors:  S Guandalini; J F Kachur; P L Smith; R J Miller; M Field
Journal:  Am J Physiol       Date:  1980-02

8.  Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Authors:  P Brazeau; W Vale; R Burgus; N Ling; M Butcher; J Rivier; R Guillemin
Journal:  Science       Date:  1973-01-05       Impact factor: 47.728

Review 9.  The use of somatostatin and its analogs in the treatment of surgical disorders.

Authors:  S Mulvihill; T N Pappas; E Passaro; H T Debas
Journal:  Surgery       Date:  1986-09       Impact factor: 3.982

10.  Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia.

Authors:  I M Modlin; S R Bloom; S Mitchell
Journal:  Experientia       Date:  1978-04-15
View more
  6 in total

1.  Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction.

Authors:  Tsunehiro Takahashi; Yoshiro Saikawa; Takahiro Igarashi; Shinichi Tsuwano; Koshi Kumagai; Rieko Nakamura; Takashi Ooyama; Norihito Wada; Hiroya Takeuchi; Hiromasa Takaishi; Yuko Kitagawa
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

2.  Acute pancreatitis, bacterial translocation, and different octreotide regimens: an experimental study.

Authors:  Osman Güler; Saadet Akturan; Erol Kisli; Iştar Dolapçi; Muzaffer Caydere; Atilla Akova
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

3.  Phasic study of intestinal homeostasis disruption in experimental intestinal obstruction.

Authors:  Xiang-Yang Yu; Chang-Lin Zou; Zhen-Li Zhou; Tao Shan; Dong-Hua Li; Nai-Qiang Cui
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

4.  Conservative treatment of early postoperative small bowel obstruction with obliterative peritonitis.

Authors:  Jian-Feng Gong; Wei-Ming Zhu; Wen-Kui Yu; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

5.  Somatostatin in inflammatory bowel disease.

Authors:  J D van Bergeijk; J H Wilson
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

6.  Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis.

Authors:  J D van Bergeijk; M E van Meeteren; C J Tak; A P van Dijk; M A Meijssen; J H Wilson; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.